The complement system in NMOSD and MG: A target for therapeutic benefit?

touchPANEL DISCUSSION for touchOPHTHALMOLOGY

Listen to a panel of leading experts discuss  the evidence for complement involvement in the pathogenesis of neuromyelitis optica spectrum disorder and myasthenia gravis, review the markers of complement activation, and highlight the implications of the latest data for complement therapeutics for practice.

The experts

• Prof. Said Beydoun, Keck School of Medicine of USC, Los Angeles, CA, USA
• Prof. Heinz Wiendl, University Hospital Münster, Münster, Germany
• Dr Pushpa Narayanaswami, Beth Israel Deaconess Medical Center, Boston, MA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Alexion Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.

To view this activity in full and to access the downloadable materials please visit: touchOPHTHALMOLOGY